Chakrabarti Advanced Technology (CAT) is a privately funded R&D Institute that conducts basic scientific research on areas of high global impact. Founded by Dr. Raj Chakrabarti (AB, Harvard; PhD, Princeton; formerly Professor of Chemical Engineering at Carnegie Mellon University and Purdue University), its focus areas include:
Our research has led to the development of cutting-edge technology platforms for drug discovery and development as well as for the development of associated companion diagnostic tests.
  • Ultrahigh-Throughput Small Molecule Drug Discovery using Computational Biophysics, Artificial Intelligence, and DNA Encoded Library
  • Passively and Actively Targeted Drug Delivery using Computational Biophysics, Nanotechnology, and Phage Display
  • Enzyme Engineering Platform

In addition to conducting internal research, it also collaborates with leading academic institutions and research centers on high impact external projects. Selected collaborators include:
  • Vanderbilt University: Discovery and Optimization of Novel cGAS Inhibitors
  • The Italian Cystic Fibrosis Foundation/University of Palermo: Targeting Nonsense Mutations via Optimization of TRIDs